Fig. 8. SNPiP facilitates murine cardiac function. After 72 h, the SNPiP-treated mice revealed increase in the EDV (P<0.05) and SV (P< 0.05), leading to increases in CO (P<0.05) and EF (P<0.05), and consequently elevated ESP (P<0.05).